Week Twelve: Bacterial Infections of Humans (Part Il)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/510

encourage image

There's no tags or description

Looks like no tags are added yet.

511 Terms

1
New cards
Bacterial meningitis
Infection causing inflammation of the meninges surrounding the brain and spinal cord.
2
New cards
Common causes of bacterial meningitis
Streptococcus pneumoniae and Neisseria meningitidis.
3
New cards
Transmission of bacterial meningitis
Respiratory secretions.
4
New cards
Pathway of bacterial meningitis
Bacteria reach the blood or spread from a nearby infection, enter the meninges and CSF, multiply, trigger inflammation, and cause swelling and increased pressure that can impair brain function.
5
New cards
Meningococcal disease
A disease caused by Neisseria meningitidis that can cause meningitis, bloodstream infection, sepsis, and a nonblanching rash.
6
New cards
Meningitis risk factors and relevant history
Recent ear or sinus infection, close exposure, vaccination history, immunosuppression, absent spleen, CSF leak, head injury, or neurosurgery.
7
New cards
Classic meningitis findings
Fever, severe headache, neck stiffness, photophobia, nausea, and vomiting.
8
New cards
Photophobia
Sensitivity to light.
9
New cards
Nonblanching rash
Pinpoint spots or purple patches that do not fade when pressure is applied; may suggest meningococcal disease.
10
New cards
Petechial rash
Small pinpoint areas of bleeding under the skin that do not blanch with pressure.
11
New cards
Meningitis neurologic warning signs
Decreased alertness, seizures, or new weakness; may indicate neurologic deterioration or increased intracranial pressure.
12
New cards
Meningitis signs of shock or organ dysfunction
Hypotension, cool or mottled skin, rapid breathing, and oliguria.
13
New cards
Important meningitis assessment point
A rash may be absent, and the full symptom pattern may be absent, especially in infants and older adults.
14
New cards
Bacterial versus viral meningitis
Symptoms alone cannot reliably distinguish bacterial from viral meningitis.
15
New cards
Blood cultures in meningitis
Help identify bacteria in the bloodstream and guide treatment.
16
New cards
Lumbar puncture (LP)
Procedure used to collect cerebrospinal fluid for testing.
17
New cards
CSF testing
Cell count, glucose, protein, Gram stain, culture, and PCR help assess inflammation and identify the cause of meningitis.
18
New cards
Typical bacterial CSF findings
Increased white blood cells, often neutrophils; increased protein; and a lower CSF-to-blood glucose ratio.
19
New cards
CT before lumbar puncture
Used selectively to assess safety before LP; CT does not replace CSF testing.
20
New cards
Meningitis precautions
Start Standard plus Droplet Precautions while meningococcal disease is possible.
21
New cards
Duration of Droplet Precautions for meningococcal or Hib disease
Continue Droplet Precautions for 24 hours of effective therapy.
22
New cards
Meningitis mask requirements
Staff wear a surgical mask on entry; mask the patient during necessary transport.
23
New cards
Meningitis treatment priorities
Prompt prescribed IV antibiotics, ordered dexamethasone with or before the first antibiotic when indicated, airway and oxygenation support, prescribed fluids, and seizure safety.
24
New cards
Meningitis reassessment
Monitor consciousness, pupils, seizures, vital signs, and urine output; escalate new deficits, falling alertness, shock, or rapidly spreading rash.
25
New cards
Meningococcal contact management
Notify infection prevention and public health; identify close contacts who may need prophylaxis.
26
New cards
Meningitis prevention and follow-up
Review meningococcal, pneumococcal, and Hib vaccination; arrange hearing and neurologic follow-up and teach warning signs.
27
New cards
Hib
Haemophilus influenzae type b.
28
New cards
Tetanus
A toxin-mediated illness that causes muscle rigidity and painful spasms.
29
New cards
Causative organism of tetanus
Clostridium tetani, an anaerobic, Gram-positive, spore-forming rod.
30
New cards
Tetanus transmission
Environmental spores in soil or fecal contamination enter through broken skin; tetanus does not spread person to person.
31
New cards
Tetanus mechanism
Spores enter a wound, germinate in low-oxygen tissue, and produce toxin that blocks nerve signals normally limiting muscle contraction.
32
New cards
Tetanus toxin effect
The toxin acts on nerves; bacteria usually remain near the wound.
33
New cards
Trismus
Lockjaw; difficulty opening the mouth.
34
New cards
Tetanus clinical findings
Jaw stiffness, difficulty swallowing, neck stiffness, persistent muscle rigidity, and painful spasms of the trunk or limbs.
35
New cards
Tetanus spasm triggers
Light, noise, or touch may trigger muscle spasms.
36
New cards
Tetanus airway complications
Throat or chest muscle spasms can block airflow or impair breathing.
37
New cards
Tetanus autonomic instability
Large blood pressure or heart-rate changes, sweating, and abnormal heart rhythm.
38
New cards
Tetanus diagnosis
Based on clinical findings and history; no laboratory test can confirm or exclude tetanus.
39
New cards
Tetanus escalation findings
Suspected tetanus, breathing difficulty, severe spasms, or unstable blood pressure or cardiac rhythm.
40
New cards
Tetanus precautions
Standard Precautions; tetanus does not spread between people.
41
New cards
Tetanus nursing priorities
Monitor breathing, SpO2, secretions, and swallowing; prepare for airway support; reduce stimulation; administer ordered sedation, muscle relaxants, analgesia, TIG, and antibiotics; assist with wound cleaning or debridement.
42
New cards
Tetanus environmental management
Keep the room quiet and dim and minimize avoidable stimulation to reduce spasms.
43
New cards
TIG
Tetanus Immune Globulin.
44
New cards
Tetanus recovery teaching
Tetanus illness does not provide immunity; give indicated vaccination once the patient is stable.
45
New cards
Tetanus wound assessment
Assess the wound and verify the patient's vaccination records and date of last dose.
46
New cards
Tetanus prophylaxis: unknown, no doses, or incomplete primary series; clean minor wound
Give tetanus vaccine; TIG is not indicated.
47
New cards
Tetanus prophylaxis: unknown, no doses, or incomplete primary series; dirty or major wound
Give tetanus vaccine plus TIG.
48
New cards
Tetanus prophylaxis: completed primary series; clean minor wound
Give a booster if the last dose was 10 or more years ago; no TIG.
49
New cards
Tetanus prophylaxis: completed primary series; dirty or major wound
Give a booster if the last dose was 5 or more years ago; TIG only for HIV or severe immunodeficiency.
50
New cards
Botulism
A rare, life-threatening illness caused by botulinum nerve toxin; it produces weakness and flaccid paralysis.
51
New cards
Causative organism of botulism
Clostridium botulinum, an anaerobic, Gram-positive, spore-forming rod.
52
New cards
Foodborne botulism
Occurs when a person swallows toxin already present in food.
53
New cards
Wound botulism
Spores enter a wound, germinate into growing bacteria, and produce toxin.
54
New cards
Infant botulism
Swallowed spores, such as those from honey, germinate in the intestine and produce toxin.
55
New cards
Botulism mechanism
Toxin blocks release of acetylcholine at peripheral nerve endings, reducing muscle stimulation and causing weakness and flaccid paralysis.
56
New cards
Acetylcholine
A nerve messenger whose release is blocked by botulinum toxin.
57
New cards
Tetanus versus botulism
Tetanus causes rigidity and spasms; botulism causes weakness and flaccid paralysis.
58
New cards
Botulism exposure history
Ask about shared or preserved foods, wounds, injection exposures, recent botulinum-toxin injections, and whether others who ate the same food are ill.
59
New cards
Botulism early findings
Double or blurred vision, ptosis, slurred speech, difficulty swallowing, and descending weakness.
60
New cards
Ptosis
Drooping of the eyelid.
61
New cards
Descending weakness in botulism
Weakness usually begins in the face and neck and moves downward on both sides.
62
New cards
Flaccid paralysis
Paralysis characterized by reduced muscle tone.
63
New cards
Botulism mental status
Alertness usually remains intact.
64
New cards
Botulism respiratory complication
Respiratory failure from weakening respiratory muscles; a weak cough or shallow breathing is concerning.
65
New cards
Botulism oxygen saturation caution
SpO2 may remain normal early even when respiratory muscle weakness is developing.
66
New cards
Botulism aspiration risk
Difficulty swallowing or managing secretions increases aspiration risk.
67
New cards
Botulism diagnostic testing
Public health coordinates serum and stool toxin tests and other indicated specimens.
68
New cards
Botulism treatment timing
Treat on clinical suspicion with expert consultation; do not wait for laboratory confirmation.
69
New cards
Botulism precautions
Standard Precautions; botulism does not spread between people.
70
New cards
Botulism nursing priorities
Assess breathing, cough, secretions, swallowing, and respiratory strength; prepare for airway support; keep NPO until swallowing safety is assessed; promptly give prescribed antitoxin.
71
New cards
Botulism antitoxin
Antitoxin limits further toxin effects but does not reverse paralysis that already exists.
72
New cards
Botulism antitoxin monitoring
Monitor the infusion for allergic reactions.
73
New cards
Wound botulism treatment
May require wound debridement and antibiotics.
74
New cards
Botulism recovery
Recovery may take weeks to months; support communication, nutrition, eye and skin care, mobility, and rehabilitation.
75
New cards
Helicobacter pylori (H. pylori)
A spiral-shaped Gram-negative bacterium associated with gastritis and peptic ulcers.
76
New cards
Gastritis
Inflammation of the stomach lining.
77
New cards
Peptic ulcer
A sore in the stomach or duodenum.
78
New cards
H. pylori adaptations
Flagella help the organism move through gastric mucus; urease helps it survive local acidity.
79
New cards
H. pylori transmission
Human-to-human spread through saliva, vomit, or stool; contaminated food or water may also contribute.
80
New cards
H. pylori disease mechanism
H. pylori colonizes gastric mucus, survives and attaches to the lining, weakens mucosal defenses through inflammation, and may cause gastritis or ulcers.
81
New cards
H. pylori symptoms
May be asymptomatic; possible burning or upper abdominal discomfort, nausea, bloating, and early fullness.
82
New cards
Other major cause of peptic ulcers
NSAID use.
83
New cards
NSAIDs
Nonsteroidal anti-inflammatory drugs.
84
New cards
H. pylori bleeding warning signs
Blood or coffee-ground emesis, black tarry stool, dizziness, or syncope.
85
New cards
H. pylori perforation or obstruction warning signs
Sudden severe abdominal pain, rigid abdomen, persistent vomiting, or inability to tolerate intake.
86
New cards
H. pylori active infection tests
Urea breath test or stool antigen test.
87
New cards
H. pylori additional testing
Endoscopy and biopsy when indicated; blood counts may help assess anemia.
88
New cards
H. pylori nursing priorities
Standard Precautions, hand hygiene, appropriate PPE for stool or vomit, prescribed antibiotics and acid-reducing medications, medication teaching, and monitoring for bleeding or deterioration.
89
New cards
H. pylori eradication follow-up
Urea breath or stool antigen test at least 4 weeks after completing antibiotics.
90
New cards
H. pylori symptom improvement
Symptom improvement does not confirm eradication; follow-up testing is needed.
91
New cards
H. pylori prevention teaching
Use teach-back for medication adherence and follow-up testing; review NSAID use with the prescriber and support smoking cessation.
92
New cards
Bacterial gastroenteritis
Acute intestinal infection causing diarrhea, abdominal cramps, vomiting, or fever.
93
New cards
Bacteria associated with gastroenteritis
Nontyphoidal Salmonella, Shigella, Campylobacter, and diarrheagenic E. coli, including Shiga toxin-producing E. coli (STEC).
94
New cards
Gastroenteritis transmission
Fecal-oral spread through contaminated food or water, contact with infected people, or animal exposure.
95
New cards
Gastroenteritis mechanism
Swallowed bacteria reach the intestine, attach and multiply and sometimes invade; toxins or inflammation alter fluid movement, causing diarrhea and fluid and electrolyte loss.
96
New cards
Gastroenteritis history
Assess onset, stool and vomit pattern, food and water exposure, travel, animal contact, sick contacts, recent antibiotics, immune status, intake, and urine output.
97
New cards
Gastroenteritis findings
Watery or bloody diarrhea, cramps, nausea, vomiting, and sometimes fever.
98
New cards
Gastroenteritis dehydration findings
Tachycardia, hypotension, dizziness, reduced urine output, or confusion.
99
New cards
Gastroenteritis hydration assessment
Assess intake, thirst, mucous membranes, heart rate, blood pressure, and urine output.
100
New cards
STEC
Shiga toxin-producing Escherichia coli.